Diabetes Core Update – September 2023

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  I’m Dr, Neil Skolnik and …   This issue will review: 1.     Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial 2.     Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade 3.     Efficacy and Safety of IDegLira Versus Basal- Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c 4.      Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people w...
Source: Diabetes Core Update - Category: Endocrinology Authors: Source Type: podcasts